Blog hero background graphic

Blog

From chatbots to agents: How GPT-5 is reshaping healthcare and pharma

Discover how GPT‑5 is transforming pharma from conversational chatbots to autonomous enterprise agents and what this shift means for...

From chatbots to agents: How GPT-5 is reshaping healthcare and pharmafeatured image

Rethinking Life Sciences Commercialization for 2026: What’s Working, What’s Not and What’s Next

The Beghou Biopharma Review

Research premiere for ‘Commercialization that Works’; direct channels reignite pharma’s patient-centricity hopes

How AI can keep life sciences innovation moving despite funding and staffing cuts

How to confront biopharma's crisis of cohesion

The new pharma equation: How DTP, DTC, and DTE are re-wiring healthcare around patients

How to make cell and gene therapy commercialization work with Rita Johnson-Greene

Introducing Beghou Arc

Introducing Beghou Arc™: Redefining life sciences commercialization

How to make cell and gene therapy commercialization work

Adrienne Lovink on Tariffs Uncertainity

How pharma marketers can prepare for Trump’s 200% tariff threat

Building omni that works — and evolves: A specialty pharma company’s approach to HCP engagement

Initial CGT launches faltered. The next wave doesn’t have to.

How to keep reps happy and compensated amidst pharma’s growing direct-to-consumer sales models

What agentic AI unlocks for pharma teams

How pharma marketers can prepare for Trump’s 200% tariff threat

Make AI work for you: From experiment to essential coworker